As part of its new cell and gene therapy access tool, HHS' first focus is improving access to sickle cell disease therapies, which can cost millions of dollars for a one-time dose. 

Biogen is discontinuing its Alzheimer's drug Aduhelm, which was approved in 2021 but became snarled in efficacy concerns and payers' refusals to cover the medication. 

After laying off 5% of its corporate workforce in November, Walgreens will lay off 145 more workers, most of whom are corporate employees, the company confirmed to Becker's. 

In January, nine more drugs fell into shortage, adding to the 300-some medications in short supply because of manufacturing delays, quality issues or high demand. 

Azurity Pharmaceuticals has recalled one lot of Zenzedi — a drug used to treat narcolepsy and ADHD — after learning that at least one bottle contained a different drug. 

An experimental drug was produced clinically meaningful pain relief among surgical and non-surgical pain conditions, and the therapy could fill the gap between safe, low-efficacy medicines and opioid treatments, its manufacturer said Jan. 30. 

As the effects of the COVID-19 pandemic have lessened, officials at Ann Arbor-based Michigan Medicine, which includes University of Michigan Health and the university's medical school, have been able to invest in innovative care, including expanding its specialty and mail-order…

Sharp HealthCare, a seven-hospital system in San Diego, partnered with a specialty pharmacy solutions provider Jan. 30.

The FDA will end emergency use authorization of Paxlovid for adult patients March 8. 

After the FDA approved the first over-the-counter emergency contraception in 2006, emergency department visits for the medication decreased by 96% over the next 14 years, according to a new study.